Journey Medical Corp. (DERM)
7.53
-0.38
(-4.80%)
USD |
NASDAQ |
Aug 25, 16:00
7.53
0.00 (0.00%)
After-Hours: 17:33
Journey Medical Total Assets (Quarterly) : 98.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 98.36M |
| March 31, 2026 | 91.53M |
| December 31, 2025 | 94.59M |
| September 30, 2025 | 85.19M |
| June 30, 2025 | 81.16M |
| March 31, 2025 | 84.96M |
| December 31, 2024 | 80.24M |
| September 30, 2024 | 64.04M |
| June 30, 2024 | 65.19M |
| March 31, 2024 | 66.57M |
| December 31, 2023 | 76.85M |
| September 30, 2023 | 65.92M |
| Date | Value |
|---|---|
| June 30, 2023 | 69.75M |
| March 31, 2023 | 95.85M |
| December 31, 2022 | 105.16M |
| September 30, 2022 | 108.14M |
| June 30, 2022 | 113.50M |
| March 31, 2022 | 120.90M |
| December 31, 2021 | 97.28M |
| September 30, 2021 | 89.06M |
| June 30, 2021 | 72.72M |
| March 31, 2021 | |
| December 31, 2020 | 51.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 1.095B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 66.24M |
| Shareholders Equity (Quarterly) | 32.11M |
| Debt to Equity Ratio | 0.7953 |
| Current Ratio | 1.590 |
| Net Debt Paydown Yield | -0.04% |